Saltar al contenido
Saltar al contenido

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 12 diciembre 2019. Database contains 224 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

 
211-765-7
693-98-1
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
10/04/2018
Details
202-112-7
91-97-4
Germany
Mutagenic
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
223-861-6
4098-71-9
Sweden
Exposure
Mutagenic
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
09/02/2018
Details
223-861-6
4098-71-9
Germany
Carcinogenic
Exposure
Mutagenic
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
201-025-1
77-40-7
France
Endocrine disruption
Under development
Under development
No suggestion yet
07/03/2017
Details
216-036-7
1478-61-1
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
20/12/2018
Details
Bisphenol A; BPA
201-245-8
80-05-7
Germany
Aggregated tonnage
Endocrine disruption
Widespread use
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
Bisphenol A; BPA
201-245-8
80-05-7
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
226-378-9
5384-21-4
France
Endocrine disruption
Persistence
Toxic for reproduction
Widespread use
Under development
Under development
No suggestion yet
11/03/2016
Details
225-863-2
5124-30-1
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
210-658-2
620-92-8
Sweden
Endocrine disruption
Other human toxicity
Under development
Under development
No suggestion yet
01/10/2015
Details
202-966-0
101-68-8
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
202-966-0
101-68-8
Denmark
Carcinogenic
Mutagenic
Other human toxicity
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
254-551-9
39635-79-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Pending
On hold
No suggestion yet
10/10/2019
Details
201-250-5
80-09-1
Belgium
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
06/03/2015
Details
250-863-4
31906-04-4
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
05/06/2015
Details
202-681-1
98-56-6
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
209-544-5
584-84-9
Denmark
Aggregated tonnage
Carcinogenic
Exposure
Mutagenic
Widespread use
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
209-544-5
584-84-9
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
202-696-3
98-73-7
Belgium
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
202-679-0
98-54-4
Germany
Endocrine disruption
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/10/2019
Details
400-370-7
-
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/09/2019
Details
217-533-1
1879-09-0
France
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Under development
Under development
No suggestion yet
07/03/2017
Details
255-288-2
41272-40-6
Netherlands
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
15/12/2017
Details
235-715-9
12607-70-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
201-469-6
83-32-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
11/12/2015
Details
203-466-5
107-13-1
Germany
Mutagenic
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
23/09/2014
Details
287-477-0
85535-85-9
Germany
Carcinogenic
Toxic for reproduction
Under development
Under development
No suggestion yet
08/07/2019
Details
287-477-0
85535-85-9
United Kingdom
Bioaccumulation
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
12/12/2019
Details
-
-
Netherlands
Carcinogenic
Exposure
Mutagenic
STOT RE
Under development
Under development
No suggestion yet
13/04/2017
Details
292-562-0
90640-43-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
This substance is identified by SDA Substance Name: N-C12-C18 alkyl propylene diamine and SDA Reporting Number: 16-032-00.
268-957-9
68155-37-3
Sweden
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
696-364-9
133779-11-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
232-565-6
9000-90-2
United Kingdom
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
12/09/2018
Details
200-539-3
62-53-3
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
None
05/07/2017
Details
233-660-5
10294-40-3
Netherlands
Carcinogenic
Concluded
Appropriate to initiate regulatory risk management action
CLH
SVHC
08/07/2019
Details
200-280-6
56-55-3
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
trimellitic anhydride; TMA
209-008-0
552-30-7
Netherlands
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
11/03/2016
Details
205-883-8
191-24-2
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
205-916-6
207-08-9
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
231-150-7
7440-41-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
19/12/2016
Details
215-133-1
1304-56-9
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
229-176-9
6422-86-2
France
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
25/01/2019
Details
223-445-4
3896-11-5
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
207-069-8
431-03-8
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
208-168-9
513-78-0
Sweden
Carcinogenic
Mutagenic
STOT RE
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
09/06/2017
Details
232-222-0
7790-79-6
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
23/09/2014
Details
244-168-5
21041-95-2
Sweden
Carcinogenic
Mutagenic
STOT RE
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
09/06/2017
Details
233-710-6
10325-94-7
Sweden
Carcinogenic
Mutagenic
STOT RE
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
09/06/2017
Details
233-331-6
10124-36-4
Sweden
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
23/09/2014
Details

Export search results to:

Categories Display


Route: .live2